Video

What Being a Survivor Means to 'The Pink Hulk', a Three-Time Cancer Survivor

Author(s):

Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE® to discuss life as a survivor.

Valerie David, writer and performer of the one-woman show “The Pink Hulk: One Woman’s Journey to Find the Superhero Within” is a three-time cancer survivor — first non-Hodgkin lymphoma, then stage 2 breast cancer and, most recently, metastatic stage 4 breast cancer. David sat down with CURE® to discuss being your own superhero and what her survivor status means to her.

“Being a survivor, what that means to me is perseverance,” David said. “It’s having that inner superhero inside you to help you with any adversity in life.”

David currently has no evidence of disease, but worries about recurrence. Despite her anxiety over this potentiality, David said, “I’m going to live my life to the fullest. And that’s what being a survivor means. Not let anything stop you from doing what you want to do in your life… We don’t know what’s going to happen but we’re not going to let that stop us.”

Related Videos
Image of doctor with brown hair.
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Related Content